Xu Dan, Yuan Liang, Liu Xin, Li Mingqi, Zhang Fubin, Gu Xin Yue, Zhang Dongwei, Yang Youlin, Cui Binbin, Tong Jinxue, Zhou Jin, Yu Zhiwei
Digestive System Department, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Department of Colorectal Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Oncotarget. 2016 May 24;7(21):31111-21. doi: 10.18632/oncotarget.9080.
The erythropoietin-producing hepatocyte (Eph) family tyrosine kinases play important roles in tumorigenesis and cancer aggression. In this study, we investigated the role of EphB6 in oncogenic transformation of colorectal epithelial cells in vitro and in vivo. EphB6 is upregulated in human colorectal cancer (CRC) tissues as compared to normal tissues, and its overexpression promotes proliferation, migration and invasion by IMCE colorectal adenoma cells, in which one Apc allele is mutated. EphB6 overexpression together with Apc mutation leads to the development of colorectal tumors in vivo. Expression microarrays using mRNAs and lncRNAs isolated from EphB6-overexpresssing IMCE and control cells revealed a large number of dysregulated genes involved in cancer-related functions and pathways. The present study is the first to demonstrate that EphB6 overexpression together with Apc gene mutations may enhance proliferation, invasion and metastasis by colorectal epithelial cells. Microarray data and pathway analysis of differentially expressed genes provided insight into possible EphB6-regulated mechanisms promoting tumorigenesis and cancer progression. EphB6 overexpression may represent a novel, effective biomarker predictive of cell proliferation, invasion and metastasis patterns in CRC tumors.
促红细胞生成素产生肝细胞(Eph)家族酪氨酸激酶在肿瘤发生和癌症侵袭中发挥重要作用。在本研究中,我们调查了EphB6在体外和体内大肠上皮细胞致癌转化中的作用。与正常组织相比,EphB6在人类结直肠癌(CRC)组织中上调,其过表达促进携带一个Apc等位基因突变的IMCE结直肠腺癌细胞的增殖、迁移和侵袭。EphB6过表达与Apc突变共同导致体内结直肠肿瘤的发生。使用从EphB6过表达的IMCE细胞和对照细胞中分离的mRNA和lncRNA进行的表达微阵列分析揭示了大量参与癌症相关功能和途径的失调基因。本研究首次证明EphB6过表达与Apc基因突变共同作用可能增强大肠上皮细胞的增殖、侵袭和转移。差异表达基因的微阵列数据和通路分析为EphB6调节促进肿瘤发生和癌症进展的可能机制提供了见解。EphB6过表达可能代表一种预测CRC肿瘤细胞增殖、侵袭和转移模式的新型有效生物标志物。